An interventional study of Light exposure, 2700 K and Light exposure, 4000 K in Insomnia, sponsored by Taipei Medical University. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-11-20.
Sponsored by Taipei Medical University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 21 studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University — 10 open to participants now, 10 under way, none of them phase 3. Sleep Initiation and Maintenance Disorders · Taipei Medical University.
Among the 21 studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University, this one is the 15th largest by enrollment of the 19 interventional ones that give a count, is one of 7 that started in 2022, is one of 19 with no phase, and was the 21st registered.
2,738 studies on the registry are indexed under Sleep Initiation and Maintenance Disorders; 735 are open to participants now.
Browse Sleep Initiation and Maintenance Disorders studies →10 of the 21 studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University are open now, in 2 countries. Recruiting first, the newest first:
Taipei Medical University · Sites in Taiwan
Ages 65+
Taipei Medical University · Sites in Taiwan
Ages 18–26 · Healthy volunteers
Taipei Medical University · Sites in Taiwan
Ages 20–65 · Healthy volunteers
Taipei Medical University · Sites in Taiwan
Ages 20–64 · Healthy volunteers
Taipei Medical University · Sites in Taiwan
Ages 18+
By country, each count listing its studies:
Of the 394 Sleep Initiation and Maintenance Disorders studies recruiting now, 156 (40%) set no upper age limit and 208 (53%) stop at 75 or younger; 61 take children under 18; 112 take healthy volunteers.
This study: 20 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
21 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 7 started in 2022.
This study's enrollment of 30 is below the median of 68 across 2,363 interventional studies indexed under Sleep Initiation and Maintenance Disorders.
Median enrollment 60 across the 19 interventional studies, 80 across the 2 observational. Of the 9 that completed or were terminated, 1 (11%) have results posted.
This tab as a report to print or save as PDF → With an account.
Taipei Medical University is the lead sponsor of 258 studies on the registry; 59 are open to participants now.
5 of the studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05402761Taipei Medical UniversityEffects of Nurse-Guided BBTi for Improving Insomnia : in Patients at the Recovery Following Traumatic Brain Injury | 2026-12 |
| NCT07114302Taipei Medical UniversityDigitally-Assisted Brief Behavioral Treatment for Insomnia in College Students | 2026-12-31 |
| NCT06853106Taipei Medical UniversityDigital Sleep Program for College Students with Insomnia | 2027-02-28 |
| NCT07880561Taipei Medical UniversityAI-Driven Digital Therapeutic for Insomnia: Development and Clinical Validation | 2027-07-31 |
| NCT07842250Taipei Medical UniversityThe Effect of Nurse-Led Mobile APP-based Brief Behavioral Therapy for Insomnia in Older Adults | 2027-07-31 |
Add all 5 to your calendar (.ics) → With an account.
Among the 21 studies in Sleep Initiation and Maintenance Disorders by Taipei Medical University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This pilot randomized study examined how the color temperature of light affects emotional states and sleep in people with insomnia symptoms. Thirty participants with an Insomnia Severity Index (ISI) score of 8 or higher were randomly allocated to 500-lux light at 2700 K, 4000 K or 6500 K. After a 7-day baseline, participants received a daily 75-minute light exposure session at 17:00 for 7 days (15 minutes of dark adaptation followed by 60 minutes of light), followed by a 7-day follow-up. Insomnia severity, depression, anxiety and stress were assessed on days 1 and 21, and sleep was recorded with actigraphy and sleep logs.
Sleep and emotional states are closely linked, and chronic sleep disturbance contributes to low mood. Light is the main external cue for the circadian system. Its non-visual effects are mediated mainly by melanopsin-containing retinal ganglion cells, which are most sensitive to short-wavelength light near 480 nm. At equal illuminance, white light with a higher color temperature has a higher melanopic equivalent daylight illuminance (melanopic EDI). Studies in healthy young adults show that higher color temperatures increase alertness and melatonin suppression, but whether repeated exposure to different color temperatures affects insomnia severity, actigraphic sleep and emotional states in people with insomnia has not been examined.
This study compared three color temperatures commonly used in LED lighting (2700 K warm white, 4000 K neutral white and 6500 K cool white) at a fixed photopic illuminance of 500 lux, a level typical of indoor lighting rather than a clinical light-therapy dose. It was hypothesized that, compared with 6500 K, lower color temperatures (2700 K and, to a lesser extent, 4000 K) would be associated with (1) greater reductions in insomnia severity, (2) improved actigraphic sleep (shorter sleep latency, higher sleep efficiency and longer total sleep time) and (3) lower anxiety, depression and stress.
This three-arm, parallel-group pilot randomized study was conducted at Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan. Participants were referred from the sleep center, psychiatric outpatient clinic, day-care center and psychologist outpatient clinic. Each participant took part for 21 days: days 1-7 baseline, days 8-14 daily light exposure, and days 15-21 follow-up. An a priori sample size of 53 was calculated (G*Power 3.1; ANCOVA, three groups, two covariates, α = 0.05, power = 0.80, f = 0.50), but recruitment was limited by the COVID-19 pandemic and the need for daily on-site sessions, so 30 participants were enrolled and the study was treated as a pilot.
The primary between-group analysis compared change scores (posttest - pretest) across the three groups with the Kruskal-Wallis test, followed by Mann-Whitney U tests. Within-group changes were examined with the Wilcoxon signed-rank test. As a secondary analysis, one-way ANCOVA was applied to posttest scores with the pretest score and caffeine intake as covariates. The Holm procedure was used to correct for multiple testing across the seven outcomes.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
- Visual impairment, cognitive deficits or communication impairments that prevent adherence to the study protocol
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive 2700 K (warm white) light at 500 lux, 75 minutes daily at 17:00 for 7 consecutive days. This is the reference condition.
Other: Light exposure, 2700 K
Participants will receive 4000 K (neutral white) light at 500 lux, 75 minutes daily at 17:00 for 7 consecutive days.
Other: Light exposure, 4000 K
Participants will receive 6500 K (cool white) light at 500 lux, 75 minutes daily at 17:00 for 7 consecutive days.
Other: Light exposure, 6500 K
On study days 8-14, a daily 75-minute session starting at 17:00: 15 minutes of dark adaptation in a fully blacked-out room, then 60 minutes of 2700 K light at 500 lux from an adjustable LED light box (63.5 × 63.5 × 14.5 cm panel with 2200 K and 6500 K LED chip sets mixed by power ratio). The light box is 96 cm from the participant with its center at eye level. Measured at eye position with a UPRtek MK350N Plus spectrometer: 473 lux, 2659 K, melanopic EDI 205.3 lux. Participants wear white or light-colored clothing and may read, but may not use electronic devices.
Same procedure, with the light box set to 4000 K at 500 lux (measured: 545 lux, 4124 K, melanopic EDI 365.1 lux).
Same procedure, with the light box set to 6500 K at 500 lux (measured: 497 lux, 6443 K, melanopic EDI 430.9 lux).
Change in insomnia severity
This study will use the Chinese version of the Insomnia Severity Index (ISI-C). It consists of seven items, each rated from 0 to 4. Total scores range from 0 to 28, with higher scores indicating more severe insomnia; a score of 8 or higher indicates insomnia. Change is calculated as the day-21 score minus the day-1 score.
Time frame: Baseline (day 1) and post-intervention (day 21)
Change in sleep latency
Time from lying down to falling asleep, in minutes, measured with a wrist-worn actigraph and averaged over 7 nights for each period. Shorter sleep latency indicates better sleep; below 30 minutes is considered optimal.
Time frame: Baseline (days 1-7) and follow-up (days 15-21)
Change in total sleep time
Total time in bed minus periods of wakefulness, in minutes, measured with a wrist-worn actigraph and averaged over 7 nights for each period. Longer total sleep time indicates better sleep.
Time frame: Baseline (days 1-7) and follow-up (days 15-21)
Change in sleep efficiency
Total sleep time divided by time in bed × 100 (%), measured with a wrist-worn actigraph and averaged over 7 nights for each period. Higher values indicate better sleep; 85% or above is considered good.
Time frame: Baseline (days 1-7) and follow-up (days 15-21)
Change in depression
This study will use the depression subscale of the Chinese version of the Depression Anxiety Stress Scales-21 (DASS-21). It consists of seven items rated from 0 (does not apply) to 3 (applies very much or most of the time). Subscale scores range from 0 to 21, with higher scores indicating more severe depression.
Time frame: Baseline (day 1) and post-intervention (day 21)
Change in anxiety
This study will use the anxiety subscale of the Chinese version of the DASS-21. It consists of seven items rated from 0 to 3. Subscale scores range from 0 to 21, with higher scores indicating more severe anxiety.
Time frame: Baseline (day 1) and post-intervention (day 21)
Change in stress
This study will use the stress subscale of the Chinese version of the DASS-21. It consists of seven items rated from 0 to 3. Subscale scores range from 0 to 21, with higher scores indicating more severe stress.
Time frame: Baseline (day 1) and post-intervention (day 21)
Plan to share: No — There is no plan to share individual participant data from this study.
No publications or documents are linked to this record.
Ran from Apr 2022 to primary completion in Sep 2022, 4 months.
Of 1,219 non-industry interventional studies with no phase under Sleep Initiation and Maintenance Disorders, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 35. This study's 4 months is below that.
Counting every sponsor, half of 1,297 studies reached it within 15 months; a quarter within 6 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sleep Initiation and Maintenance Disorders →